Relevant bibliographies by topics / Tumor Residual

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Tumor Residual'

Author: Grafiati
Published: 9 March 2023
Last updated: 19 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tumor Residual.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tumor Residual"

1

Kasbekar, Anand, Guleed Adan, Alaina Beacall, Ahmed Youssef, Catherine Gilkes, and Tristram Lesser. "Growth Patterns of Residual Tumor in Preoperatively Growing Vestibular Schwannomas." Journal of Neurological Surgery Part B: Skull Base 79, no. 04 (2017): 319–24. http://dx.doi.org/10.1055/s-0037-1607421.

Full text
Abstract:
Objectives To analyze growth of residual vestibular schwannoma (VS) following incomplete tumor resection and determine the influence of residual location and size. Design Retrospective case note and scan review. Setting Tertiary skull base unit. Participants Patients with residual tumor following primary surgery for medium and large unilateral growing vestibular schwanomas between 2006 and 2009. Main Outcome Measures Location of residual VS and post-operative growth, comparing those with more (>5%) or less than 5% of tumor residual (<5%). Results Fifty-two patients had visible residual t
APA, Harvard, Vancouver, ISO, and other styles
2

Panni, Roheena Z., Ivan Gonzalez, Christopher P. Hartley, et al. "Residual Tumor Index." American Journal of Surgical Pathology 42, no. 11 (2018): 1480–87. http://dx.doi.org/10.1097/pas.0000000000001144.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wittekind, Christian, and Paul Hermanek. "Residual Tumor Classification." Advances in Anatomic Pathology 2, no. 4 (1995): 277–79. http://dx.doi.org/10.1097/00125480-199507000-00055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kishida, Takeshi. "Postchemotherapy residual tumor." Annals of Oncology 28 (October 2017): ix52. http://dx.doi.org/10.1093/annonc/mdx627.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Xu, Xiaohong, Liangping Luo, Jiexin Chen, et al. "Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound." BioMed Research International 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/901642.

Full text
Abstract:
Aim. To explore acoustic radiation force impulse (ARFI) elastography in assessing residual tumors of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA).Materials and Methods. There were 83 HCC lesions among 72 patients. All patients were examined with ARFI, contrast enhanced ultrasound (CEUS), and CT or MRI. Tumor brightness on virtual touch tissue imaging (VTI) and shear wave velocity (SWV) were assessed before and approximately one month after RFA.Results. There were 14 residual tumors after RFA. VTI showed that all the tumors were darker after RFA. VTI was not able to distin
APA, Harvard, Vancouver, ISO, and other styles
6

Yi, Huiming, Baohuan Cai, Xi Ai, Kaiyan Li, Pengfei Song, and Wei Zhang. "Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model." BioMed Research International 2020 (September 27, 2020): 1–9. http://dx.doi.org/10.1155/2020/2462058.

Full text
Abstract:
Objective. It is difficult to evaluate the ablation effect immediately after thermal ablation of liver cancer by clinical imaging methods, due to the immediate formation of an annular inflammatory reaction band (IRB). This study is aimed at exploring the early identification indicators of the IRB and residual tumor postmicrowave ablation (MVA) using contrast-enhanced ultrasonography (CEUS). Methods. MVA was used to inactivate part of the tumor nodules in rabbit VX2 liver cancer models, leading to the coexistence of the IRB with residual tumors. Quantitative analysis of the perfusion parameters
APA, Harvard, Vancouver, ISO, and other styles
7

Widhalm, Georg, Stefan Wolfsberger, Matthias Preusser, et al. "Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression." Journal of Neurosurgery 111, no. 3 (2009): 563–71. http://dx.doi.org/10.3171/2008.4.17517.

Full text
Abstract:
Object In residual nonfunctioning pituitary adenomas, reliable prognostic parameters indicating probability of tumor progression are needed. The Ki 67 expression/MIB-1 labeling index (LI) is considered to be a promising candidate factor. The aim in the present study was to analyze the clinical usefulness of MIB-1 LI for prognosis of tumor progression. Methods The authors studied a cohort of 92 patients with nonfunctioning pituitary adenomas. Based on sequential postoperative MR images, patients were classified as tumor free (51 patients) or as harboring residual tumor (41 individuals). The res
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Zhiming, Hala S. Hassanain, Erin He, et al. "Abstract P3-02-28: A combination approach to target residual tumors via ferroptosis induction." Clinical Cancer Research 31, no. 12_Supplement (2025): P3–02–28—P3–02–28. https://doi.org/10.1158/1557-3265.sabcs24-p3-02-28.

Full text
Abstract:
Abstract Background: Selection pressure from chemotherapy can result in small populations of resistant cells, even in tumors with apparent clinical response. These residual tumor cells can tolerate cytotoxic treatments, persist in a reversible, semi-dormant, diapause-like state, and ultimately drive tumor recurrence. Pharmacologically targeting these residual tumor cells has the potential to prevent or significantly delay tumor relapse, but it remains a clinical challenge. Methods and Results: We report ferroptosis induction as a targeting strategy to eradicate residual tumor cells following c
APA, Harvard, Vancouver, ISO, and other styles
9

De Santis, Maria, Alexander Becherer, Carsten Bokemeyer, et al. "2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial." Journal of Clinical Oncology 22, no. 6 (2004): 1034–39. http://dx.doi.org/10.1200/jco.2004.07.188.

Full text
Abstract:
Purpose To define the clinical value of 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG PET) as a predictor for viable residual tumor in postchemotherapy seminoma residuals in a prospective multicentric trial. Patients and Methods FDG PET studies in patients with metastatic pure seminoma who had radiographically defined postchemotherapy residual masses were correlated with either the histology of the resected lesion or the clinical outcome documented by computer tomography (CT), tumor markers, and/or physical examination during follow-up. The size of the residual lesions on CT, ei
APA, Harvard, Vancouver, ISO, and other styles
10

Lusch, A., and P. Albers. "Residual tumor resection (RTR)." World Journal of Urology 35, no. 8 (2016): 1185–90. http://dx.doi.org/10.1007/s00345-016-1984-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tumor Residual"

1

Takeda, Kazuna. "MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy." Kyoto University, 2012. http://hdl.handle.net/2433/157449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Oliveira, Marcelo de Lima. "Ultrassonografia durante cirurgia para metástase cerebral: influência no índice de Karnofsky e volume do tumor residual." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5138/tde-09082016-151729/.

Full text
Abstract:
Introdução: Os principais objetivos do tratamento das metástases cerebrais (MC) são no auxílio do controle da doença no encéfalo e a melhora da qualidade de vida dos pacientes. A cirurgia convencional tem um importante papel no tratamento das MCs e os métodos de monitoração intraoperatória podem auxiliar na obtenção de resultados cirúrgicos melhores. Objetivos: Avaliar a influência da ultrassonografia encefálica durante cirurgia para ressecção de MC no índice de Karnofsky e no grau de ressecção do tumor. Métodos: Neste estudo prospectivo controlado e não randomizado, doentes com indicação de t
APA, Harvard, Vancouver, ISO, and other styles
3

Costa-Gurgel, Maria Salete 1956. "Aspectos histologicos relacionados com a persistencia de tumor residual apos conização em pacientes com carcinoma microinvasivo do colo uterino." [s.n.], 1994. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310012.

Full text
Abstract:
Orientador: Aloisio José Bedone<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-07-19T18:28:24Z (GMT). No. of bitstreams: 1 Costa-Gurgel_MariaSalete_M.pdf: 1948436 bytes, checksum: 9652cc74f1c4e8abd0a8359398a304a0 (MD5) Previous issue date: 1994<br>Resumo: O tratamento do carcinoma microinvasivo do colo uterino é bastante controverso, sendo abordado diferentemente nos diversos Serviços. A histerectomia, acompanhada ou não de procedimentos mais radicais, é realizada na quase totalidade dos casos. Mais recentement
APA, Harvard, Vancouver, ISO, and other styles
4

Marighetti, P. "RESIDUAL DORMANT CANCER STEM CELL FOCI ARE RESPONSIBLE FOR TUMOR RELAPSE AFTER ANGIOGENIC METRONOMIC THERAPY IN HEPATOCELLULAR CARCINOMA XENOGRAFTS." Doctoral thesis, Università degli Studi di Milano, 2012. http://hdl.handle.net/2434/169919.

Full text
Abstract:
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor and the third leading cause of cancer-related death. Current available chemotherapeutic options are not curative due in part to their resistance to conventional therapies. We have generated orthotopic HCC mouse models in immunodeficient NOD/SCID/IL2rγ null mice by injection of AFP- and/or luciferase-expressing HCC cell lines and primary cells from patients, where tumor growth and spread can be accurately monitored in a non-invasive way. Low dose metronomic administration of cyclophosphamide (LDM-CTX) causes in this model comp
APA, Harvard, Vancouver, ISO, and other styles
5

Vu-Han, Tu-Lan [Verfasser], and Reinhard [Akademischer Betreuer] Schneppenheim. "Identifying Molecular Markers for the Sensitive Detection of Residual Atypical Teratoid Rhaboid-Tumor Cells / Tu-Lan Vu-Han. Betreuer: Reinhard Schneppenheim." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2016. http://d-nb.info/1082347604/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vu-Han, Tu-Lan Verfasser], and Reinhard [Akademischer Betreuer] [Schneppenheim. "Identifying Molecular Markers for the Sensitive Detection of Residual Atypical Teratoid Rhaboid-Tumor Cells / Tu-Lan Vu-Han. Betreuer: Reinhard Schneppenheim." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2016. http://nbn-resolving.de/urn:nbn:de:gbv:18-77221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Morales, Murillo Serafín. "Cáncer de mama: utilidad pronóstica de los Perfiles de Expresión Proteica en pacientes con tumor residual viable (>1.0cm.) tras Quimioterapia neoadyuvante." Doctoral thesis, Universitat de Lleida, 2015. http://hdl.handle.net/10803/401677.

Full text
Abstract:
La identificació de marcadors moleculars en el tumor residual després de quimioteràpia neoadjuvant ( QTN ) en Càncer de Mama permet una millor caracterització pronostica . S'han seleccionat un total de 256 pacients amb QTN entre 1996 i 2011 , amb tumor residual ( > 1 cm ) . S'ha realitzat una matriu matricial de teixits i estudi inmunohistoquimic de l'expressió de 29 marcadors moleculars . L'anàlisi s'ha realitzat sobre l'aparició de metàstasi i la supervivència lliure de progressió a distància . El model multivariant ( mètode stepwise ) obté una signatura molecular amb sis marcadors de mal pr
APA, Harvard, Vancouver, ISO, and other styles
8

PEIRETTI, MICHELE. "Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. single institution experience." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2010. http://hdl.handle.net/10281/8049.

Full text
Abstract:
Objective. The objective of the present study was to determinate the impact of maximal cytoreductive surgery on progression free survival, overall survival rates and morbidity, in patients with advanced epithelial ovarian or fallopian tube cancer (stage IIIC-IV) treated in a referral cancer center. Methods. After obtaining Institutional Review Board approval, we reviewed all medical records of patients with stage IIIC–IV epithelial ovarian cancer who were managed at our institution between January 2001 and December 2008. Individual records were reviewed and the following information collected
APA, Harvard, Vancouver, ISO, and other styles
9

Milano, Jeronimo Buzetti. "Estudo das alterações em exames de ressonância magnética de pacientes em pós-operatório imediato de ressecção de tumores hipofisários por via transesfenoidal." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5138/tde-22062010-125138/.

Full text
Abstract:
Exames pós-operatórios de cirurgias intracranianas são difíceis de serem interpretados por apresentarem alterações morfológicas que simulam situações patológicas, como edema e tumores residuais. Com o advento de métodos de ressonância intraoperatória essa interpretação ganhou maior importância, pelo risco de re-intervenções desnecessárias. O presente estudo objetivou estabelecer as características de exames pós-operatórios normais após remoção de tumores hipofisários pela via transesfenoidal endonasal, bem como estabelecer parâmetros de remoção tumoral radical para otimização de exames intraop
APA, Harvard, Vancouver, ISO, and other styles
10

Rick, Oliver. "Therapieoptimierungsverfahren bei Patienten mit rezidivierten oder progredienten Keimzelltumoren." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2004. http://dx.doi.org/10.18452/13921.

Full text
Abstract:
Patienten mit metastasierten Keimzelltumoren, die einen Progress oder ein Rezidiv ihrer Erkrankung nach einer cisplatinhaltigen Vortherapie erleiden, haben eine schlechte Prognose. Unter Verwendung einer erneuten konventionellen Chemotherapie können maximal 15-30% dieser Patienten geheilt werden, so dass die Mehrzahl der Patienten an ihrer Erkrankung verstirbt. Aus diesem Grund ist die Optimierung der therapeutischen Möglichkeiten ein wesentliches Ziel. Unsere Daten zeigen, dass die Hochdosischemotherapie (HDCT) eine wesentliche therapeutische Verbesserung darstellt und mittels dieser Therapie
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tumor Residual"

1

Ignatiadis, Michail, Christos Sotiriou, and Klaus Pantel, eds. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28160-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

International Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor (1989 Vancouver, B.C.). Effects of therapy on biology and kinetics of the residual tumor: Proceedings of an International Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor, held in Vancouver, British Columbia, Canada, February 15-18, 1989. Edited by Ragaz J. 1945-. Wiley-Liss, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

F, Zipf Theodore, and Johnston Dennis A, eds. Leukemia and lymphoma: Detection of minimal residual disease. Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ljung, Gunilla. Radiotherapy of prostatic adenocarcinoma: With reference to local cure characterization or residual tumour cells adverse effects. Acta Universitatis Upsaliensis, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer Berlin / Heidelberg, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Reizenstein, P., and G. Mathe. Managing Minimal Residual Malignancy in Man (Medical Oncology and Tumor Pharmacotherapy). Elsevier Science Publishing Company, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Majmundar, Neil, and James K. Liu. Ventricular Tumors. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0009.

Full text
Abstract:
Central neurocytomas are rare benign tumors that are typically located in the lateral ventricles. Because they are typically intraventricular, these tumors tend to present clinically with hydrocephalus. Currently, surgical removal with a gross-total resection is the treatment of choice. Various radiotherapy techniques, including both conventional radiotherapy and stereotactic radiosurgery, have been shown to be useful in cases of residual tumor after subtotal resection and tumor recurrence. This chapter presents a clinical case of central neurocytoma that demonstrates the typical clinical and
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tumor Residual"

1

Cirillo, Luigi, Antonella Bacci, Raffaele Agati, and Marco Leonardi. "Early Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Caranci, Ferdinando, Francesco Briganti, and Arturo Brunetti. "Late Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stecco, Alessandro, Francesco Fabbiano, Sara Zizzari, et al. "Low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fabbiano, Francesco, Alessandro Stecco, Sara Zizzari, et al. "High-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "High-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Teicher, Beverly A. "Models for Minimal Residual Tumor." In Anticancer Drug Development Guide. Humana Press, 1997. http://dx.doi.org/10.1007/978-1-4615-8152-9_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stecco, Alessandro, Francesco Fabbiano, Sara Zizzari, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pantel, K., and M. Otte. "Disseminated Tumor Cells: Diagnosis, Prognostic Relevance, and Phenotyping." In Minimal Residual Disease in Melanoma. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-59537-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tumor Residual"

1

Sharma, Khushi, Vivan Jaiswal, Tapan Kumar Dey, Shishir Singh Chauhan, Aditya Narayan Hati, and Mahesh Jangid. "Brain Tumor Detection and Classification Using Attention Based Residual Learning." In 2025 International Conference on Next Generation Communication & Information Processing (INCIP). IEEE, 2025. https://doi.org/10.1109/incip64058.2025.11019958.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Liu, Zhipeng, Yidong Cao, Zeyuan Ju, Qiong Fu, Yi Ou, and Shangce Gao. "A Novel MRI Brain Tumor Detection Method Incorporated Residual Dendritic Learning." In 2024 Joint 13th International Conference on Soft Computing and Intelligent Systems and 25th International Symposium on Advanced Intelligent Systems (SCIS&ISIS). IEEE, 2024. https://doi.org/10.1109/scisisis61014.2024.10760086.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Saeed, Abdullah, Namrata Dhanda, and Kapil Kumar Gupta. "Enhanced Brain Tumor Detection via ResNet50 Classification and Residual U-Net Segmentation." In 2025 2nd International Conference on Computational Intelligence, Communication Technology and Networking (CICTN). IEEE, 2025. https://doi.org/10.1109/cictn64563.2025.10932530.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Prakash, Ankur, Mahima Jaiswal, Chakrapani Singh, and Vibhav Prakash Singh. "Semantic Segmentation of Brain Tumor Images Using Attention-based Residual U-Net Model." In 2024 International Conference on Control, Computing, Communication and Materials (ICCCCM). IEEE, 2024. https://doi.org/10.1109/iccccm61016.2024.11039928.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tiwari, Pradeep Kumar, and Prashant Johri. "Revolutionizing Brain Tumor Analysis: Unleashing the Potential of Residual UNet for Enhanced Segmentation Accuracy." In 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE). IEEE, 2024. http://dx.doi.org/10.1109/icacite60783.2024.10617138.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Velmurugan, L., R. K. Maheswari, K. Janani, K. Agalya, M. Poornima, and K. C. Gayathri. "Enhanced Framework for MRI Brain Tumor Recognition with Residual Learning and Intuitive Heatmap Visualization." In 2024 International Conference on Innovative Computing, Intelligent Communication and Smart Electrical Systems (ICSES). IEEE, 2024. https://doi.org/10.1109/icses63760.2024.10910526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Elagamy, Mahmoud, Hossam Selim, and Saleh Mesbah Elkaffas. "Enhanced Brain Tumor Detection and Segmentation Using Identity Generative Adversarial Network and Attention Residual U-Net." In 2023 33rd International Conference on Computer Theory and Applications (ICCTA). IEEE, 2023. https://doi.org/10.1109/iccta60978.2023.10969194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ullah, Muhammad Sami, Emaan Nazeeruddin, Muhammad Attique Khan, and Saddaf Rubab. "Brain Tumor Classification from MRI Scans using a Custom 4-Residual Deep Learning Architecture and Particle Swarm Optimization." In 2024 6th International Symposium on Advanced Electrical and Communication Technologies (ISAECT). IEEE, 2024. https://doi.org/10.1109/isaect64333.2024.10799805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dharaneswar, Sholingapuram, and B. P. Santosh Kumar. "An In-Depth Method for Liver Tumor Segmentation and Classification using Trans-UNet and Vision Transformer-based Residual Attention Network." In 2024 5th International Conference on Electronics and Sustainable Communication Systems (ICESC). IEEE, 2024. http://dx.doi.org/10.1109/icesc60852.2024.10689998.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Stylianopoulos, Triantafyllos, John D. Martin, Vikash P. Chauhan, Lance L. Munn, and Rakesh K. Jain. "Residual Stresses in Solid Tumors: Implications to Tumor Growth and Drug Delivery." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80235.

Full text
Abstract:
The uncontrolled growth of cancer cells within a confined tissue space generates residual stresses in solid tumors [1,2]. These stresses contribute to tumor progression, pathological cellular behavior, and compression of lymphatic and blood vessels [3–5]. A major consequence of vascular compression is a decrease in pathways available for blood flow and delivery of diagnostic and therapeutic agents, resulting in insufficient and heterogeneous delivery of chemotherapy and nanomedicine. The reduced perfusion also causes hypoxia and acidity — two important barriers to treatment efficacy and promot
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tumor Residual"

1

Kengsakul, Malika, Gatske Nieuwenhuyzen – de Boer, and Heleen van Beekhuizen. Radiological factors associated with residual disease after cytoreductive surgery for advanced ovarian cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0059.

Full text
Abstract:
Review question / Objective: Which radiological factors associated with incomplete cytoreduction (gross residual disease) after cytoreductive surgery (CRS) for advanced ovarian cancer? Condition being studied: Findings of CT scan and discussion in the multidisciplinary tumor board meeting (MDO) are crucial to determine the therapeutic strategy for individual ovarian cancer patients. Preferably, patients undergo primary cytoreductive surgery (CRS) followed by adjuvant chemotherapy. However, when complete cytoreduction is not considered feasible, neoadjuvant chemotherapy followed by interval cyt
APA, Harvard, Vancouver, ISO, and other styles
2

Wu, Yingyue, Jia Luo, Jiani Ding, Lingxia Wang, and Bing Wei. Evidence mapping of histopathologic classification systems to characterize residual tumor in patients undergoing neoadjuvant treatment for breast cancer, including TNBC. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.8.0026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tumor Residual' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography